(Q35457095)

English

Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid

scientific article published on 12 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Alex Frydrychowicz

object named as

Alex Frydrychowicz

1

0 references

Scott B. Reeder

object named as

Scott B Reeder

5

0 references

author name string

Scott K Nagle

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sharon L D'Souza

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Karl K Vigen

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

12 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Journal of Magnetic Resonance Imaging

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

585-594

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

Comparison of reconstruction accuracy and efficiency among autocalibrating data-driven parallel imaging methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

Variable echo time imaging: signal characteristics of 1-M gadobutrol contrast agent at 1.5 and 3T.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

Bilateral ce-MR angiography of the hands at 3.0 T and 1.5 T: intraindividual comparison of quantitative and qualitative image parameters in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

Intraindividual comparison of high-spatial-resolution abdominal MR angiography at 1.5 T and 3.0 T: initial experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

Intracranial time-resolved contrast-enhanced MR angiography at 3T.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

SENSE: sensitivity encoding for fast MRI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

Signal-to-noise measurements in magnitude images from NMR phased arrays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

12 July 2018

Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

Influence of multichannel combination, parallel imaging and other reconstruction techniques on MRI noise characteristics

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

High spatial resolution T1-weighted MR imaging of liver and biliary tract during uptake phase of a hepatocyte-specific contrast medium.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202678

26 September 2018

Contrast-enhanced abdominal MR angiography: optimization of imaging delay time by automating the detection of contrast material arrival in the aorta

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22713

21 January 2018

Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/21751288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence

1 reference

https://pubmed.ncbi.nlm.nih.gov/21751288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contrast-enhanced MR imaging of the liver: comparison between Gd-BOPTA and Mangafodipir

1 reference

https://pubmed.ncbi.nlm.nih.gov/21751288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA

1 reference

https://pubmed.ncbi.nlm.nih.gov/21751288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21751288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations

1 reference

https://pubmed.ncbi.nlm.nih.gov/21751288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/21751288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21751288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gadoxetic acid disodium-enhanced magnetic resonance imaging for biliary and vascular evaluations in preoperative living liver donors: comparison with gadobenate dimeglumine-enhanced MRI

1 reference

https://pubmed.ncbi.nlm.nih.gov/21751288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/JMRI.22713

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35457095&oldid=1861502581"